RadNetRDNT
About: RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
Employees: 10,288
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
59% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 32
22% more funds holding in top 10
Funds holding in top 10: 9 [Q2] → 11 (+2) [Q3]
20% more capital invested
Capital invested by funds: $3.63B [Q2] → $4.35B (+$713M) [Q3]
7% more funds holding
Funds holding: 275 [Q2] → 294 (+19) [Q3]
1.18% more ownership
Funds ownership: 83.51% [Q2] → 84.69% (+1.18%) [Q3]
1% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 100
59% less call options, than puts
Call options by funds: $7.5M | Put options by funds: $18.3M
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Truist Securities David Macdonald 67% 1-year accuracy 29 / 43 met price target | 0%upside $80 | Buy Maintained | 23 Sept 2024 |
Jefferies Brian Tanquilut 67% 1-year accuracy 6 / 9 met price target | 0%upside $80 | Buy Maintained | 19 Sept 2024 |
Barclays Andrew Mok 38% 1-year accuracy 14 / 37 met price target | 1%downside $79 | Overweight Upgraded | 6 Sept 2024 |
Financial journalist opinion
Based on 8 articles about RDNT published over the past 30 days